Morality Clinical Trial
Official title:
A Comparative Study of Using Scorpion Antivenom Versus Scorpion Antivenom and Prazosin Drug for Scorpion Stings Management in Sohag University Hospitals
Interventional study designed for the evaluation of characters and the outcome of scorpion sting patients will admit to Sohag University Hospitals in 2 randomized groups. The first group will receive scorpion antivenom only whether by the intravenous or the intramuscular route of administration. The second group will receive a combination of prazosin plus scorpion antivenom whether by the intravenous or the intramuscular route of administration. Both groups will receive proper first aid and supportive treatment
Tools of the study: 1. Dose and administration of prazosin: 30 μg/kg/dose of prazosin will be delivered orally every 6 hours 4 doses, in adults we shouldn't exceed 1 mg per dose. Prazosin will be delivered using a nasogastric tube while securing the patient's airway in the event of vomiting or unconsciousness. Every 30 minutes for the first three hours, every hour for the following six, and then every four hours until improvement, blood pressure, pulse rate, respiration rate, and oxygen saturation will be measured. When pain is the only symptom, prophylaxis shouldn't be given. To avoid the first-dose phenomenon, the patient should remain in a laying position for around 3 hours (even while the case is being examined) (Shoreit et al., 2019). Dose of antivenom 1-1 ampoule intramuscular and/ or, 2-1 to 5 Polyvalent anti-scorpion serum ampoules produced by the vaccine & serum institution (VACSERA)in Egypt according to the severity of the case on 200 to 500 ml glucose 5% infusion and assess the patient clinically to repeat the dose after 4 to 6 hours. (Shoreit et al., 2019) 2. A prepared sheet containing 1. the demographic characteristics of each patient 2. Vital signs and degree of coma at time of admission of the patient. 3. First aid management as resuscitation. 4. Supportive management will be done to the patients during the admission will be recorded. 5. Cardiac enzymes measurements, duration of hospital stay and the outcome of patients in each group. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03079726 -
Use of Device Data to Predict Frailty in Individuals
|
||
Not yet recruiting |
NCT05447611 -
Role of Empathy in Curative Treatment Outcomes of Non-metastatic Colorectal Cancer.
|
||
Completed |
NCT05268419 -
Efficacy and Safety of Ethanol Inhalation on COVID-19 Treatment (a Clinical Trial Study)
|
Phase 3 | |
Completed |
NCT05042804 -
Perioperative Outcome Risk Assessment With Computer Learning Enhancement
|
N/A | |
Recruiting |
NCT03628313 -
Valvular Aortic Stenosis Prognosis Study
|
||
Completed |
NCT05527678 -
5 Years Quality of Life and Early Mobilization in ICU
|
||
Recruiting |
NCT05088109 -
Shock Indices Use for Early Mortality From Septic Shock
|
||
Recruiting |
NCT05073991 -
Incidence of Mortality and Complications After Lung Surgery, Open Thoracic Aortic Repair, TEVAR, EVAR.
|
||
Completed |
NCT05844410 -
Evaluation of Corticosteroids Use and Clinical Outcomes in Hospitalized COVID-19 Patients: A Retrospective Study
|
||
Recruiting |
NCT05585593 -
Registry for Hypoparathyroidism Wuerzburg
|
||
Recruiting |
NCT03834246 -
Smoke Inhalation Injury in Patients Admitted to Intensive Care
|
||
Completed |
NCT03919032 -
Bacterial Infections in Patients With Cirrhosis in Argentina: Clinical and Microbiological Characteristics
|
||
Completed |
NCT05116670 -
Comparison of Care Practices, Mortality and Morbidity of Very Preterm Infants Between Two Tertiary Centers in Northwest and South of China
|
||
Withdrawn |
NCT04531839 -
Improving Outcome of Very Preterm Infants Using Collaborative Quality Improvement
|
N/A | |
Recruiting |
NCT04685278 -
Anticardiolipin Autoantibodies and Mortality in Septic Patients
|
||
Not yet recruiting |
NCT03665987 -
The Effect of Preoperative Assessment Clinic on Prognosis and Economic Results of Patients With Coexisting Disease.
|
||
Completed |
NCT04049565 -
CRP Versus PCT as Bio-markers for Sepsis and in Guiding Antibiotics in Critically Ill Patients
|
||
Completed |
NCT04971278 -
Evaluating the Impact of a Supportive Care Program
|
||
Recruiting |
NCT06087315 -
Evaluation of a Multi-country Medical Oxygen Program
|
||
Completed |
NCT03344627 -
Clinical Outcome Study of High-dose Meropenem in Sepsis and Septic Shock Patients
|
N/A |